Von Seggern Christopher 4
4 · Xenon Pharmaceuticals Inc. · Filed Aug 17, 2020
Insider Transaction Report
Form 4
Von Seggern Christopher
Chief Commercial Officer
Transactions
- Award
Stock Option (Right to Buy)
2020-08-17+100,000→ 100,000 totalExercise: $11.27Exp: 2030-08-16→ Common Shares (100,000 underlying)
Footnotes (1)
- [F1]Vesting 25% on the one year anniversary of the grant date, and 75% vesting thereafter over the course of the next 3 years, in equal amounts, on the last day of each month.